During the COVID-19 pandemic, many U.S. hospitals had overcapacity intensive care units while other area hospitals had open ICU beds available, a phenomenon known as “load imbalance.”
In experiments of unprecedented scale, researchers at Weill Cornell Medicine and the NIH have advanced efforts to better understand and ultimately treat this common metabolic disease.
An interdisciplinary collaboration used a cutting-edge form of RNA tagging to map the gene expression that occurs during follicle maturation and ovulation in mice, an approach that could lead to therapeutic treatments for infertility.
Weill Cornell Medicine is constructing a modern student residence that, when it opens in 2025, will nearly double the existing student residential living space.
Removing race information from cardiovascular risk calculators – which predict the probability of developing heart disease – doesn’t affect patients’ risk scores, according to a study by Weill Cornell Medicine and NewYork-Presbyterian investigators.
Researchers at Weill Cornell Medicine have found that controlling high blood pressure may not be enough to prevent associated cognitive declines. The findings suggest new approaches to prevent damage to brain cells.
The 14th episode of a podcast hosted by Entrepreneurship at Cornell, Startup Cornell, features David Stein MBA ‘20, co-founder and CEO of Ash Wellness.
Deer hunters were more likely to be swayed by social media messages about the potential risks of chronic wasting disease if they came from a source they believed aligned with their own views and values.
New research has shown that ultrasmall Cornell Prime Dots, or C’Dots, which are among the nanocarriers for therapeutics once thought to be viable only by injection, have the potential to be administered orally.